Ignite Creation Date:
2024-05-05 @ 10:23 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01093326
Status:
COMPLETED
Last Update Posted:
2023-10-12
First Post:
2010-03-24
Brief Title:
Clinical Study to Investigate the Long-term Safety Tolerability and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Multicenter Randomized Double-blind Parallel-group Extension to Study AC-058B201 to Investigate the Long-term Safety Tolerability and Efficacy of Three Doses of Ponesimod an Oral S1P1 Receptor Agonist in Patients With Relapsing-remitting Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an extension to the study AC-058B201 and will investigate the long-term safety tolerability and efficacy of ponesimod in patients with relapsing-remitting multiple sclerosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2009-011470-15 | EUDRACT_NUMBER | None | None |